Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1998-12-10
2000-08-01
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514169, 514177, 514178, 514912, 514914, A61K 3156
Patent
active
060967331
ABSTRACT:
A topical drug application for the alleviation of kerato-conjunctivitis sicca (dry eye syndrome) is comprised of a solution of 17-.beta.-estradiol suspended or dissolved in a vehicle, and the method of preparation and application of the same. In the preferred embodiments, 17-.beta.-estradiol is in a lipid vehicle or 17-.beta.-estradiol 3-phosphate disodium dissolved in an aqueous vehicle having a pH of between about 6 to about 8. This invention may also be useful in treating other conditions where KCS may occur, such as post-operative corneal transplant patients and patients who cannot receive replacement estrogen therapy.
REFERENCES:
patent: 4642305 (1987-02-01), Johansson et al.
patent: 4774236 (1988-09-01), Cook et al.
patent: 4861763 (1989-08-01), Cook et al.
patent: 4866049 (1989-09-01), Maumenee et al.
patent: 5041434 (1991-08-01), Lubkin
Ostrogen-Therapie in Keratokonjunktivitis Sicca, Dr. J. Akramian et al., Spektrum der Augenheilkunde (Spektrum Augenheilkd.) Nov. 5, 1997 (195-97).
Olige Estradio-Hemihydrat-Augentropfen 0.025 Prozent; Fischer, H and Reimann H., Neues Rezeptur-Formularium (NRF) Pharmazeutisches Laboratorium, Pharmazeutische Zeitung (Pharm. Ztg.) Jan. 14, 1999 144/2 (38-40).
Benitez del Castillo, J.M.E, et al., "ffects of Estrogen Use on Lens Transmittance in Postmenopausal Women," Ophthalmology 1997; 104:970-973.
Sator, M.O., et al., "Treatment of menopausal keratoconjunctivitis sicca with topical oestradiol," Br. J. Obstet. Gyn. 1998; 105:100-102.
Fay Zohreh
Lubkin Virginia
LandOfFree
Drugs for topical application of sex steroids in the treatment o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drugs for topical application of sex steroids in the treatment o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drugs for topical application of sex steroids in the treatment o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-664056